Deliang Guo
University of Ottawa(CA)Xuzhou Medical College(CN)The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(US)Quantum Technologies (Sweden)(SE)The Ohio State University(US)Shanghai Institute of Technology(CN)
Publications by Year
Research Areas
Cancer, Lipids, and Metabolism, Cholesterol and Lipid Metabolism, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer, RNA modifications and cancer
Most-Cited Works
- → Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19(2020)1,181 cited
- → Lipid metabolism reprogramming and its potential targets in cancer(2018)810 cited
- → An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway(2011)442 cited
- → EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy(2009)341 cited
- → Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress(2020)324 cited
- → Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth(2015)323 cited